PRESS RELEASE published on 01/19/2024 at 12:41, 2 years 3 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research has published an update on Cardiol Therapeutics Inc., reaffirming its BUY recommendation and maintaining the price target of USD 3.60. The report highlights the progress in patient recruitment for CardiolRx's two lead indications, acute myocarditis (AM) and recurrent pericarditis (RP), with expectations of significant near-term catalysts for the stock. Analyst Christian Orquera remains optimistic about the company's investment potential. For the full analysis, visit the link provided. Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Patient Recruitment Investment Potential
PRESS RELEASE published on 08/30/2023 at 15:06, 2 years 8 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 05/24/2023 at 13:01, 2 years 11 months ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 04/11/2023 at 15:26, 3 years 1 month ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
Published on 05/14/2026 at 14:50, 19 minutes ago Germany's BGR Assesses NextSource Materials' Molo Graphite Mine as Part of Federal Critical Minerals Study
Published on 05/14/2026 at 14:30, 39 minutes ago Boron One Holdings Inc. Completes Its Jarandol Basin Exploration Program for 2026
Published on 05/14/2026 at 14:00, 1 hour 9 minutes ago Adcore Reports First Quarter 2026 Results: Revenue Up 22% to CAD $8.5 Million, as APAC Grows 42% to CAD $5.5 Million
Published on 05/14/2026 at 14:00, 1 hour 9 minutes ago Alaska Energy Metals Provides Update On The Nikolai Nickel Project, Alaska / Permitting - Metallurgy - Government Collaboration
Published on 05/14/2026 at 13:30, 1 hour 39 minutes ago Alset AI Announces First Quarterly Renewal of Lyken.AI Cloud Compute Services Contract with Multinational Technology and Telecommunications Company
Published on 05/14/2026 at 14:54, 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 05/14/2026 at 14:52, 16 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 05/13/2026 at 17:45, 21 hours 24 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 21 hours 24 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 21 hours 29 minutes ago Report on share repurchases from 6 to 12 May 2026
Published on 05/13/2026 at 16:00, 23 hours 9 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
